Sun Pharma

No plans to get into vaccine production as it requires separate manufacturing infra: Sun Pharma

Commenting on the company's Halol plant, which has been under the USFDA radar for the last few years, Shanghvi said the drug firm is waiting for the regulator to inspect the facility.

If Nifty continues to trade below 15,600, it may touch 15,510; HCL Tech, Sun Pharma look strong on charts

The larger texture of the market is still on the bullish side and likely to continue in the near term, said an analyst

HCL Tech, Sun Pharma, Asian painst, nifty

Sun Pharmaceuticals rating – Buy: One-offs impacted the bottomline in Q4

Steady progress in sales of specialty products; the momentum is likely to be sustained; ‘Buy’ retained with TP raised to Rs 815

Sun Pharma Q4 net profit zooms over twofold to Rs 894.15 crore

The company had posted a net profit of Rs 399.84 crore in the corresponding period of the previous fiscal, Sun Pharma said in a regulatory filing.

Sun Pharmaceutical Industries

TCS, ICICI Bank, other must-have stocks: Time to rejig investment portfolio post Budget 2021? INTERVIEW

Investment advisor Sandip Sabharwal tells that the biggest driver of the markets now is easy liquidity which needs to be monitored.

Union Budget 2021, TCS, ICICI Bank, PSU banks

Pharma shares regaining momentum, resuming up-trend; here’s how to shape your stock portfolio

Based on technical analysis, ICICI Direct has carved out a list of stocks that makes a multi-cap pharma stock portfolio.

Stocks, Nifty, Sensex

Stocks to buy ahead of Budget 2021: IRCTC, HUL, Maruti, HCL Tech, more; these sectors to be in focus

Union Budget 2021 India: Ahead of Union Budget 2021, market watchers have advised a few sectors and stocks which may remain in focus during this week.

Budget 2021-22, Union Budget 2021

BSE Healthcare index doubles from March lows on COVID vaccine hopes; 3 healthcare stocks look set to gain

Economic indicators have started turning positive which could start the upgrade cycle and liquidity flows across Emerging Markets could remain strong which bodes well for Indian markets.

stock, divis lab, ipca laboratories, sun pharma

Sun Pharma share price rallies 62% from March lows; should you buy the stock? Check target prices

Sun Pharmaceuticals Industries stock has been on a gaining spree since it touched a 52-week low of Rs 315.20 in March this year

लॉकडाउन के सिंकदर! निवेशकों ने खामोशी से कमा लिए 16 लाख करोड़, अप्रैल में यहां हुई धुंआधार कमाई

अप्रैल यानी सिर्फ 1 महीने में ही शेयर बाजार ने करीब 19 फीसदी रिटर्न दे दिया.

sensex and nifty performance April, stock market top gainers in April, investors wealth rose by 16 lakh crore rs in April during lockdown, RIL, Maruti, HCL, hero motocorp, sunpharma, HDFC, ICICI Bank

COVID-19: कोरोना के कहर में भी कमाई कराते रहे ये शेयर, क्या आगे भी बना सकते हैं मालामाल?

कोरोना संकट में भी बीएसई 100 यानी टॉप 100 कंपनियों के कुछ शेयरों का प्रदर्शन इस साल अच्छा र

brokerage top stock idea, these stocks rose YTD amid in corona virus concern, HUL, Biocon, Nestle India, Airtel, sunpharma, top bets in stock market, brokerage favorite stocks

सनफार्मा: 1700 करोड़ के बाय बैक को मंजूरी, शेयर धारकों के पास 15% रिटर्न पाने का मौका

सनफार्मा ने 1700 करोड़ रुपये के शेयर बाय बैक का एलान किया है.

M-cap of top seven companies decline by Rs 45,963 cr

The combined market valuation of top seven companies declined by Rs 45,962.77 crore last week with IT majors -- Infosys and TCS -- taking the maximum hit.

BSE Sensex, NSE Nifty

Sun Pharma enters into derma segment

The company will co-promote Suncros brand across prescription and consumer channels to drive growth Sun Pharma will focus on dermatology as the fourth engine of growth for its OTC business. As part of this growth strategy, th

Sun Pharma announces divestment of US manufacturing units

Divests two units to Frontida BioPharm

Sun Pharma sells two US-based plants to Frontida BioPharm

Drug major Sun Pharmaceutical Industries has sold two of its US-based manufacturing facilities along with 15 products to Frontida BioPharm Inc for an undisclosed amount.

Sun Pharmaceutical shares

Sun’s problems to linger on for 2-3 quarters: Jefferies

Headwinds plaguing the country's largest drug-maker Sun Pharmaceutical will continue for next two-three quarters owing to pricing pressures and regulatory issues dogging its Halol plant, says a report.

Sun Pharma revenue growth guidance at 8-10 pc for FY’17

Sun Pharma also said that its board has decided to evaluate a proposal for buyback of equity shares and will hold a meeting on June 23 for the purpose.

Sun Pharmaceutical shares

Sun Pharma shares fall 6% on weak sales guidance

Sun Pharmaceutical Industries shares plunged nearly 6 per cent in late morning trade on Tuesday after the pharma company posted a weaker-than expected annual sales outlook as it grappled with increased competition in the Unit

Sun Pharmaceutical shares

Sun Pharma Q4 profit at Rs 1,713.69 cr

Country's largest drug maker Sun Pharmaceutical Industries today reported a consolidated net profit of Rs 1,713.69 crore for the fourth quarter ended March 31, 2016.

Sun Pharmaceutical shares

M-cap of top 10 companies swells by Rs 98,598 cr, ITC biggest gainer

Driven by a sharp rally in the stock market last week, the combined market valuation of top- 10 most valued Indian companies soared by a whopping Rs 98,598 crore, with ITC emerging as the biggest mover.

Sensex crashes over 500 points today after strikes against Pakistan, how investors reacted during Kargil War

Sun Pharma shares surge over 5% on termination of transition pact with Daiichi

Sun Pharma shares rallied after it said that the umbrella pact and transaction agreements signed with Daiichi Sankyo and its overseas subsidiaries have been terminated due to divestment of Ranbaxy by the Japanese firm.

Sun Pharmaceutical shares

Sun Pharma launches mobile app for asthma patients

RespiTrack seeks to enable doctors to track treatment progress of their patients and increase compliance to medication

Nine of top 10 bluechip companies lose Rs 47,932 cr in market cap

The combined market valuation of nine of the top 10 most valued Indian companies diminished by Rs 47,932.59 crore last week, with IT major TCS taking the biggest hit.

Late buying helps Sensex recover, end 120 points up; Nifty reclaims 8,600 mark

ICGEB and Sun Pharma sign agreement to develop botanical drug to treat dengue

ICGEB will provide the technical know-how and pre-clinical expertise and Sun Pharma to develop this drug with appropriate pre-clinical & clinical studies to register it in India and other global markets

Sun Pharma announces positive results of two phase-III CTs of Tildrakizumab

The IL-23p19 Therapeutic Antibody meets primary endpoints in both placebo-controlled studies and secondary endpoint in active-comparator etanercept arm

ICMR, MoHFW, Govt. of Madhya Pradesh and Sun Pharma in agreement for Malaria Free India

Partnership to demonstrate malaria elimination in over 1,200 villages of MP's Mandla district by FY21

Income Tax Calculator, Budget 2019, How to Calculate Income Tax


Stock Market

Most Read


Top News


Related Articles